Sergey Sheleg
From Wikipedia, the free encyclopedia
Dr. Sheleg is a recognized researcher in the fields of neuro-oncology, pathogenesis of slow viral neuro-infection diseases (Creutzfeldt-Jakob disease, etc.) and anoxic/hypoxic brain damage/brain death. His recent research data showed the absence of severe autolytic damage of the brain cortical neurons for four hours of warm (+20°C) cardiac arrest.
Contents |
[edit] Research experience
Dr. Sheleg has over 15 years of experience in the fields of neuromorphology, neuro-oncology, and pathogenesis of brain death. Being a Medical Oncologist/Research Associate he studied the problem of management of malignant brain tumors (designing new methods for local chemotherapy of the incurable malignant brain tumor — glioblastoma multiforme) at Research Institute of Oncology and Medical Radiology (Republic of Belarus) for eight years. At the same time he worked on the problem of designing new methods for preventing severe hypoxic brain damage after long-term cardiac arrest. Over 2002-2005, Dr. Sheleg worked as a Visiting Research Scientist at the Center for Biologics Evaluation and Research of the U.S. Food and Drug Administration and at National Institutes of Health (National Institute of Allergy and Infectious Diseases) in the field of molecular cell biology. Over 2005-2006, he worked as a Research Scientist at the Alcor Life Extension Foundation on the problem of anoxic brain damage and its prevention. Currently Dr. Sheleg is continuing research in the field of designing the new hypothermic preservation technology based on using the clathrate-forming substances at low temperatures and under high pressure.
[edit] Education
Dr. Sheleg got his M.D. at Minsk State Medical School (Republic of Belarus) and his Ph.D. in Oncology at Research Institute of Oncology and Medical Radiology (Republic of Belarus). He is an author of one book and more than 30 research articles. He holds 2 patents for a new prolonged form of the antitumor drug cisplatin for local chemotherapy of malignant brain tumors.
